Keywords: angiotensin, ii, antagonists, europe, future, merck, co

Angiotensin II Antagonists In Europe: What Future?

Article | 06 November 1995

Print This

Merck & Co of the USA launched the first angiotensin II antagonist Cozaar (losartan) onto the market in 1994. There are a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in